At its Annual General Meeting held yesterday, innoscripta SE (“innoscripta”, ISIN: DE000A40QVM8) shareholders approved a dividend of EUR 4.00 per share for the 2025 financial year, with all agenda items adopted by a majority of over 97.6%. The meeting also saw the re-election of Philipp von Ilberg, Stefan Berndt-von Bülow and Dr. Erik Massmann to the Supervisory Board, a move that bolsters the board's expertise in capital markets, finance and international corporate development.
Philipp von Ilberg, who serves as Chairman of the Supervisory Board of CompuGroup SE & Co. KGaA, brings extensive experience in complex corporate and capital markets transactions. Stefan Berndt-von Bülow has a strong background as CFO in listed technology companies and successfully led a NASDAQ IPO. Dr. Erik Massmann, most recently CFO of the Birkenstock Group, was responsible for its NYSE IPO and numerous international finance and transformation projects. Their combined expertise positions the Supervisory Board to support innoscripta's capital markets strategy and further international growth.
Shareholders also approved the relocation of the company’s registered seat from Munich to Tutzing. The relocation, already implemented, aims to establish a clearer organizational structure with key central functions at the new headquarters, while operational units remain in Munich, Cologne and Frankfurt. This move strengthens group efficiency, provides fiscal benefits, and creates a solid foundation for growth, particularly in international markets.
A total of 91.7% of the share capital was represented at the meeting. Full voting results are available in the Investors section of the company’s website at https://www.innoscripta.com/en/investoren/hauptversammlung-2026.
innoscripta SE offers Clusterix, a scalable software platform for structured organization and management of research and development activities. Companies use Clusterix to efficiently manage innovation projects, digitize internal processes, and make R&D activities transparent and scalable.
